Recent Patents on Anti-Cancer Drug Discovery

Review of Selected Patents for Cancer Therapy Targeting Tumor Angiogenesis
pp. 153-161(9)
Authors: Kirstein, Mark N.; Moore, Megan M.; Dudek, Arkadiusz Z.

Recent Developments to Improve the Efficacy of Cytotoxic Nucleoside Analogues
pp. 163-170(8)
Authors: Jordheim, Lars P.; Galmarini, Carlos M.; Dumontet, Charles

Thymidine Phosphorylase (Platelet-Derived Endothelial Cell Growth Factor) as a Target for Capecitabine: From Biology to the Bedside
pp. 171-183(13)
Authors: Ranieri, Girolamo; Roccaro, Aldo M.; Vacca, Angelo; Ribatti, Domenico

Tetraplex Binding Molecules as Anti-Cancer Agents
pp. 185-200(16)
Authors: Doherty, Kevin M.; Sharma, Sudha; Gupta, Rigu; Brosh Jr., Robert M.

Innovative Cancer Treatments that Augment Radiotherapy or Chemotherapy by the Use of Immunotherapy or Gene Therapy
pp. 201-208(8)
Authors: Lucas, Rudolf; Keisari, Yona

EGF-R Small Inhibitors and Anti-EGF-R Antibodies: Advantages and Limits of a New Avenue in Anticancer Therapy
pp. 209-222(14)
Authors: Caraglia, Michele; Marra, Monica; Meo, Giuseppina; Addeo, Santolo R.; Tagliaferri, Pierosandro; Budillon, Alfredo

Endogenous Angiogenesis Inhibitors as Therapeutic Agents: Historical Perspective and Future Direction
pp. 223-236(14)
Authors: Dhanabal, Mohanraj; Sethuraman, Natarajan

The Place of Somatostatin Analogs in the Diagnosis and Treatment of the Neuoroendocrine Glands Tumors
pp. 237-254(18)
Authors: Melen-Mucha, Gabriela; Lawnicka, Hanna; Kierszniewska-Stepien, Dorota; Komorowski, Jan; Stepien, Henryk

Recent Patents Therapeutic Agents for Cancer
pp. 255-284(30)
Authors: Li, Xun; Xu, Wenfang

Recent Developments in the Field of Anticancer Platinum Complexes
pp. 285-295(11)
Author: Galanski, Markus

Patent Annotations
pp. 297-302(6)

Patent Selections
pp. 303-304(2)